tiprankstipranks
Gain Therapeutics (GANX)
NASDAQ:GANX
US Market

Gain Therapeutics (GANX) Stock Investors

Compare
255 Followers
Based on 788,174 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold GANX
On average, investors allocate 0.00% of their portfolios to GANX
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 788,174 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding GANX

3.2%
Last 7
Days
12.4%
Last 30
Days
Percentages indicate the change in the number of portfolios holding GANX, out of 788,174 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

GANX Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.20%
$1.04
Based on the activity of investors who made their portfolios public
The table shows changes in GANX in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

GANX Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Plug Power
5.02%
-1.28%
-2.16%
1.63B
Industrials
DraftKings
5.07%
-1.00%
-1.47%
43.65B
Consumer Cyclical
Lucid Group
5.55%
-0.27%
+0.42%
9.97B
Consumer Cyclical
Nio
9.06%
-1.42%
-1.80%
9.00B
Consumer Cyclical
Viking Therapeutics
3.90%
-0.95%
+1.82%
3.52B
Healthcare
Marathon Digital Holdings
5.08%
-0.88%
-2.42%
5.41B
Financial
Riot Platforms
4.81%
-1.98%
-0.62%
3.99B
Financial
Recursion Pharmaceuticals
3.68%
+3.89%
+7.93%
4.04B
Healthcare
Trade Desk
3.54%
+2.94%
+13.56%
37.38B
Technology
General Motors
4.74%
-1.08%
-0.47%
47.65B
Consumer Cyclical
Based on the activity of 788,174 active portfolios
Open your Smart Portfolio

GANX Investor Analysis

GANX investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
2.4%
of GANX holders
are under 35
Average Segment Performance
Average P/E Ratio39.08
Beta11.18
Dividend Yield3.84%
GANX investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
54.8%
of GANX holders
are between 35–55
Average Segment Performance
Average P/E Ratio37.72
Beta20.89
Dividend Yield3.28%
GANX investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
42.9%
of GANX holders
are over 55
Average Segment Performance
Average P/E Ratio36.08
Beta10.18
Dividend Yield3.48%
Overview of age group and performance of GANX stock investors
See who invests in GANX according to age group and performance.

FAQ

How many retail Investors hold GANX?
<0.1% of TipRanks' retail investors hold GANX in their portfolios.
    What is GANX Investor Sentiment?
    GANX’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of GANX in the last 7 days?
      ▼ 3.2% of TipRanks' retail investors changed their holding of GANX in the last 7 days.
        What percentage of retail investors changed their holding of GANX in the last 30 days?
        ▼ 12.4% of TipRanks' retail investors changed their holding of GANX in the last 30 days.
          What is the average age of retail investors who hold GANX?
          The average age of GANX Holders is between 35–55.
            What other stocks have GANX investors also bought?
            GANX Investors also bought PLUG, DKNG, LCID, NIO, VKTX, MARA, RIOT, RXRX, TTD, GM.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALKSAlkermes
              BDXBecton Dickinson
              CNCCentene
              CHRSCoherus Biosciences
              CICigna
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis